
1. malar j. 2015 jan 19;14:4. doi: 10.1186/1475-2875-14-4.

coil: methodology evaluating malarial complexity infection using
likelihood single nucleotide polymorphism data.

galinsky k(1), valim c(2), salmier a(3), de thoisy b(4), musset l(5), legrand
e(6), faust a(7), baniecki ml(8), ndiaye d(9), daniels rf(10)(11), hartl
dl(12)(13), sabeti pc(14)(15), wirth df(16)(17), volkman sk(18)(19)(20), neafsey 
de(21).

author information: 
(1)department biostatistics, harvard school public health, boston, ma,
02115, usa. kgalinsky@gmail.com.
(2)department immunology infectious disease, harvard school public
health, boston, ma, 02115, usa. cvalim@hsph.harvard.edu.
(3)laboratoire de parasitologie, national reference centre malaria, institut 
pasteur de la guyane, cayenne, french guiana, france. arielle.salmier@gmail.com.
(4)laboratoire de parasitologie, national reference centre malaria, institut 
pasteur de la guyane, cayenne, french guiana, france.
bdethoisy@pasteur-cayenne.fr.
(5)laboratoire de parasitologie, national reference centre malaria, institut 
pasteur de la guyane, cayenne, french guiana, france. lmusset@pasteur-cayenne.fr.
(6)laboratoire de parasitologie, national reference centre malaria, institut 
pasteur de la guyane, cayenne, french guiana, france.
elegrand@pasteur-cayenne.fr.
(7)faculty arts sciences, harvard university, cambridge, ma, 02138, usa.
afaust@college.harvard.edu.
(8)broad institute mit harvard, cambridge, ma, 02142, usa.
baniecki@broadinstitute.org.
(9)faculty medicine pharmacy, cheikh anta diop university, dakar, senegal.
daouda.ndiaye@ucad.edu.sn.
(10)faculty arts sciences, harvard university, cambridge, ma, 02138, usa. 
rdaniels@broadinstitute.org.
(11)broad institute mit harvard, cambridge, ma, 02142, usa.
rdaniels@broadinstitute.org.
(12)faculty arts sciences, harvard university, cambridge, ma, 02138, usa. 
dhartl@oeb.harvard.edu.
(13)broad institute mit harvard, cambridge, ma, 02142, usa.
dhartl@oeb.harvard.edu.
(14)faculty arts sciences, harvard university, cambridge, ma, 02138, usa. 
pardis@broadinstitute.org.
(15)broad institute mit harvard, cambridge, ma, 02142, usa.
pardis@broadinstitute.org.
(16)department immunology infectious disease, harvard school public
health, boston, ma, 02115, usa. dfwirth@hsph.harvard.edu.
(17)broad institute mit harvard, cambridge, ma, 02142, usa.
dfwirth@hsph.harvard.edu.
(18)department immunology infectious disease, harvard school public
health, boston, ma, 02115, usa. svolkman@hsph.harvard.edu.
(19)broad institute mit harvard, cambridge, ma, 02142, usa.
svolkman@hsph.harvard.edu.
(20)simmons college school nursing health sciences, boston, ma, 02115,
usa. svolkman@hsph.harvard.edu.
(21)broad institute mit harvard, cambridge, ma, 02142, usa.
neafsey@broadinstitute.org.

background: complex malaria infections defined containing 
one genetically distinct lineage plasmodium parasite. complexity infection 
(coi) useful parameter estimate patient blood samples 
associated clinical outcome, epidemiology disease transmission rate.
this manuscript describes method estimating coi using likelihood, called
coil, panel bi-allelic genotyping assays.
methods: coil assumes distinct parasite lineages complex infections are
unrelated genotyped loci exhibit significant linkage
disequilibrium. using population minor allele frequency (maf) the
genotyped loci, coil uses binomial distribution estimate likelihood of
a coi level given prevalence observed monomorphic polymorphic genotypes
within sample.
results: coil reliably estimates coi level three five least
24 96 unlinked genotyped loci, respectively, determined silico
simulation empirical validation. evaluation coi levels greater five
in patient samples may require large collection genotype data, making
sequencing cost-effective approach evaluating coi conditions
when disease transmission extremely high. performance method is
positively correlated maf genotyped loci. coi estimates from
existing snp genotype datasets create detailed portrait disease than
analyses based simply number polymorphic genotypes observed within
samples.
conclusions: capacity reliably estimate coi genome-wide panel of
snp genotypes provides potentially accurate alternative methods relying
on pcr amplification small number loci estimating coi. approach 
will also increase number applications snp genotype data, providing
additional motivation employ snp barcodes studies disease epidemiology 
or control measure efficacy. coil program available download from
github, users may also upload snp genotype data web interface 
simple efficient determination sample coi.

doi: 10.1186/1475-2875-14-4 
pmcid: pmc4417311
pmid: 25599890  [indexed medline]

